Krebs Biochemicals & Industries Ltd.

NSE : KREBSBIO

Add Alert

Add Watchlist

₹70.06

-1.24 (-1.74%) - 3 Oct 2025 09:21 AM

NSE : KREBSBIO

About Company

Krebs Biochemicals & Industries Limited (KBIL) is an India-based company. The Company operates in the pharma segment. The Company’s products include lavastatin, simvastatin and simvastatin ammonium salt. The Company specializes in the fermentation technology. The Company has two manufacturing facilities: Unit-1 at Regadichelaka, Nellore district, and Unit-2 at Kothapalli Village, Kasimkota Mandal, Vishakapatnam district. Products manufactured from Unit I facility are ephedrine, pseudoephedrine and their salts, which are used for making formulations for respiratory ailments, such as cough and cold.

Market Cap. ₹ 154 Cr.

52 Week - High/Low ₹ 129/66

P/E Ratio

P/B Ratio

Enterprise Value ₹ 365 Cr.

ROE % N/A

RSI Value 39.16

EMA 50 76.5

EMA 200 80.7

Market Cap. ₹ 154 Cr.

52 Week - High/Low ₹ 129/66

P/E Ratio N/A